DDC Adds 131 Bitcoin to 2714 BTC Treasury; Two Purchases in Seven Days Lift Per-Share Bitcoin Exposure 13.9%

DDC Enterprise Limited (NYSE American: DDC) ("DDC" or the "Company"), a global Asian food platform and digital asset treasury company, today disclosed the purchase of an additional 131 Bitcoin ("BTC"), expanding the Company's corporate Bitcoin treasury to 2,714 BTC. Bitcoin per 1,000 DDC shares rose by 5.1% to 0.057053. DDC continues to rank among the top 30 publicly traded corporate Bitcoin holders worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527178101/en/

DDC Now Holds 2,714 BTC

DDC Now Holds 2,714 BTC

Today marks DDC's second Bitcoin purchase in seven days, following the 200 BTC acquired on May 21. The two transactions have together added 331 BTC and lifted Bitcoin holdings by approximately 13.9%, with no new common shares issued. The 131 BTC size of today's transaction reflects available liquidity and balance sheet capacity, consistent with the Company's approach of deploying capital in measured, opportunistic increments rather than committing at any single price.

Bitcoin Purchase Highlights

  • BTC Acquired: 131 BTC
  • Total Bitcoin Holdings: 2,714 BTC
  • Average Cost per Bitcoin: $79,135
  • BTC Yield (Year-to-Date): 43.5%
  • BTC per 1,000 Shares: 0.057053

"Discipline in a Bitcoin treasury is proven through repetition," said Norma Chu, Founder, Chairwoman, and Chief Executive Officer of DDC Enterprise. "Today's purchase puts capital we previously raised to work, without printing a single new share to do it. Our mandate is straightforward: get more Bitcoin behind every DDC share, and keep proving that mandate one transaction at a time."

DDC intends to keep building its Bitcoin treasury under the same framework that guided today's purchase: deploying capital raised above per-share Bitcoin NAV in measured, opportunistic increments rather than committing at any single price. The broader objective is to compound durable value across both the operating business and the balance sheet so that each DDC share represents more Bitcoin, a stronger Asian food platform, and a deeper capital base over time.

About DDC Enterprise Limited

DDC Enterprise Limited (NYSE American: DDC) is a global Asian food platform and digital asset treasury company. The Company operates a portfolio of leading Asian food brands that generated $39.2 million in fiscal year 2025 revenue with first-time positive Adjusted EBITDA, and it holds one of the largest corporate Bitcoin treasuries among NYSE-listed consumer companies. DDC is led by Founder, Chairwoman, and Chief Executive Officer Norma Chu. For more information, visit www.ddc.xyz .

Caution Regarding Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" or other similar expressions. Examples of forward-looking statements include those related to business prospects, accumulation of Bitcoin, the Company and its management's view of market conditions and outlook, and the Company's goals, strategy and future activity. These statements are subject to uncertainties and risks including, but not limited to, the risk factors discussed in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 20-F, 6-K and other reports filed with the Securities and Exchange Commission ("SEC") and available at www.sec.gov . It is also inherent in forward-looking statements for there to be risks, uncertainties and other factors beyond the Company's ability to predict or control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's filings with the SEC. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov . The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law.

Media & Investor Contacts

D DC Investor Relations
Orange Group | Yujia Zhai
ddc@orangegroupadvisors.com

DDC Press and Media
pr@ddc.xyz

News Provided by Business Wire via QuoteMedia

DDC
The Conversation (0)

Streamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update Presentation

Streamex Corp. ("Streamex" or the "Company") (NASDAQ: STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced webcast details for its earnings and corporate update presentation to be held on Wednesday, April 8, 2026, at 4:30 p.m.... Keep Reading...

Streamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update Presentation

Streamex Corp. ("Streamex" or the "Company") (NASDAQ: STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced webcast details for its earnings and corporate update presentation to be held on Wednesday, April 8, 2026, at 4:30 p.m.... Keep Reading...
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

NUV-1511 is the first clinical candidate from the company's novel drug-drug conjugate platform Company anticipates initiating a Phase 1/2 clinical study of NUV-1511 in 1H 2024 Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by... Keep Reading...
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

Phase 1 monotherapy study of NUV-868 and Phase 1b study of NUV-868 in combination with olaparib or enzalutamide are ongoing Expect to submit an IND for first Drug-Drug Conjugate (DDC) clinical candidate by year end 2023 Strong balance sheet with cash, cash equivalents, and marketable securities... Keep Reading...
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Enrollment ongoing in the Phase 1b study of NUV-868 in combination with olaparib or enzalutamide Enrollment ongoing in the Phase 1 monotherapy study of NUV-868 Expect to submit an IND for first Drug-Drug Conjugate (DDC) clinical candidate by year end 2023 Announced formation of oncology-focused... Keep Reading...
AmeriTrust Announces First Quarter 2026 Financial Results

AmeriTrust Announces First Quarter 2026 Financial Results

TORONTO, ON / ACCESS Newswire / May 27, 2026 / AmeriTrust Financial Technologies Inc. (TSXV:AMT,OTC:AMTFF)(OTCQB:AMTFF)(Frankfurt:1ZVA) ("AmeriTrust", "AMT" or the "Company"), a fintech platform focused on automotive finance, announces that it has filed its interim Consolidated Financial... Keep Reading...
Steven Boms

From Skepticism to Action: Steve Boms on Canada’s Open Banking Turning Point

Canada is shaping its financial future through open banking.Steve Boms, executive director of FDATA North America, made a recent appearance on the Investing News Network podcast, where he detailed Canada’s long-awaited transition toward consumer-driven banking and how placing the Bank of Canada... Keep Reading...
AmeriTrust Announces 2025 Annual Financial Results

AmeriTrust Announces 2025 Annual Financial Results

TORONTO, ON / ACCESS Newswire / April 22, 2026 / AmeriTrust Financial Technologies Inc. (TSXV:AMT,OTC:AMTFF)(OTCQB:AMTFF)(Frankfurt:1ZVA) ("AmeriTrust", "AMT" or the "Company"), a fintech platform targeting automotive finance, is announcing that it has filed its audited Consolidated Financial... Keep Reading...

Charles Schwab's Money Talk Personal Finance Column Expands Bench of Expert Voices

Three new Certified Financial Planners ® join the column's roster of experts creating real-life financial education insight Charles Schwab today announced the addition of three new Certified Financial Planners® to Money Talk, Schwab's personal finance column designed to help everyday Americans... Keep Reading...

Climate Global and Moody's Power the First Index and ETF of Climate-Resilient REITs

Climate Global and Exchange Traded Concepts announced the Climate Global Climate-Resilient REIT Index ETF (Ticker: CLIM), an exchange-traded fund designed to provide exposure to U.S. equity Real Estate Investment Trusts (REITs) while systematically incorporating insurance-grade climate and... Keep Reading...

T. ROWE PRICE OHA SELECT PRIVATE CREDIT FUND ANNOUNCES DECEMBER 31, 2025 FINANCIAL RESULTS AND DECLARED TOTAL DISTRIBUTIONS OF $0.69 PER SHARE IN Q4 2025

T. Rowe Price OHA Select Private Credit Fund (the "Company" or "OCREDIT") today reported financial results and total distributions of $0.69 per share for the quarter ended December 31, 2025. As private credit remains a key driver of financing solutions within credit markets, OCREDIT closed the... Keep Reading...

Interactive Chart

Latest Press Releases

Related News